Global Motion Sickness Treatment Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a XX% CAGR of around XX% during a forecast period.To know about the Research Methodology :- Request Free Sample Report The symptoms intricate in motion sickness like nausea, vomiting, dizziness, headache and irritability. Around 75% to 80% population undergoes from motion sickness in travelling. Therefore, considering the frequency and cause of Motion sickness disorder is indicating the growth of Motion Sickness Treatment Market. The scope of the report includes a detailed study of global and regional markets for Motion Sickness Treatment with the reasons given for variants in the growth of the industry in certain regions.The development of obesity-related disorders like diabetes, cardiovascular diseases and others have substantially increased in last two years, and these are responsible for growth of motion sickness treatment market. However, introduction of generic transdermal scopolamine patches in the U.S. and availability of other such products in Asia Pacific are feasible to hamper the motion sickness treatment market. Further, the motion sickness treatment market is segmented with availability of enormous number of OTC products across the globe. Nevertheless, increase in disposable income and rise in number of domestic and international travelers are estimated to drive the motion sickness treatment market in forecast period. The report on Motion Sickness Treatment market covers segments such as Treatment Type, Route of Administration, Distribution Channel and Region. The Treatment Type segment includes Anticholinergic, Antihistamines Sympathomimetic, Traditional Medicines and Others. Among the Treatment Type, Antihistamines Sympathomimetic is accounted for the largest XX% market share in the Motion Sickness Treatment market. The Route of Administration segment is further sub-segmented into Oral, Transdermal, Parenteral and Other. Among the Route of Administration, Oral route of administration is accounted for the largest XX% market share in the Motion Sickness Treatment market. Based on Distribution Channel, the Motion Sickness Treatment market is sub-segmented into Retail Pharmacies, Online Pharmacies, Drug Stores and Others. Amongst them Retail Pharmacies are accounted for the largest XX% market share in the global Motion Sickness Treatment market. Based on regional segment, the global Motion Sickness Treatment market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America was dominating market for Motion Sickness Treatment Market in 2018. Increased acceptance of recommendation of motion sickness drugs in the U.S. is a key factor for griping the large share of the region. Europe holds second position in the Motion Sickness Treatment Market. Increase in number of travelers is expected to grow the Motion Sickness Treatment Market in Europe. Asia Pacific is witnessed as the developing motion sickness treatment market in recent few years. Rise in disposable income and increase in number of domestic and international travelers are expected to boost the motion sickness treatment market in Asia Pacific. Key players operating in the Motion Sickness Treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc., Myungmoon Pharm Co. Ltd., Baxter International Inc., Reliefband Technologies LLC., and CVS Health. Most of these key players are emphasize on brand enlargement over the promotion of new product or drug alternates. Nevertheless, there are several small and mid-sized OTC product suppliers functioning in the international and regional markets. For example, the first generic to transdermal scopolamine patch was hosted in the U.S. in 2017, although regional players are introducing their transdermal scopolamine systems in Asia Pacific since 2000. These factors are responsible for growth of motion sickness treatment market across the globe. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global Motion Sickness Treatment market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the global Motion Sickness Treatment market.
Scope of the Global Motion Sickness Treatment Marketl: Inquire before buying
Global Motion Sickness Treatment Market, By Treatment Type
• Anticholinergic • Antihistamines Sympathomimetic • Traditional Medicines • OthersGlobal Motion Sickness Treatment Market, By Route of Administration
• Oral • Transdermal • Parenteral • OtherGlobal Motion Sickness Treatment Market, By Distribution Channel
• Retail Pharmacies • Online Pharmacies • Drug Stores • OthersGlobal Motion Sickness Treatment Market, By Region
• North America • Europe • Asia Pacific • Middle East & Africa • South AmericaKey players operating in the Global Motion Sickness Treatment Market
• GlaxoSmithKline plc. • Perrigo Company plc. • Prestige Brands Inc. • WellSpring Pharmaceutical Corporation • Caleb Pharmaceuticals Inc. • Myungmoon Pharm Co. Ltd. • Baxter International Inc. • Reliefband Technologies LLC. • CVS Health
Global Motion Sickness Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Motion Sickness Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Motion Sickness Treatment Market Analysis and Forecast 6.1. Global Motion Sickness Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Motion Sickness Treatment Market Analysis and Forecast, By Treatment Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Motion Sickness Treatment Market Value Share Analysis, By Treatment Type 7.4. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, By Treatment Type 7.5. Global Motion Sickness Treatment Market Analysis, By Treatment Type 7.6. Global Motion Sickness Treatment Market Attractiveness Analysis, By Treatment Type 8. Motion Sickness Treatment Market Analysis and Forecast, By Route of Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Motion Sickness Treatment Market Value Share Analysis, By Route of Administration 8.4. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, By Route of Administration 8.5. Global Motion Sickness Treatment Market Analysis, By Route of Administration 8.6. Global Motion Sickness Treatment Market Attractiveness Analysis, By Route of Administration 9. Motion Sickness Treatment Market Analysis and Forecast, By Distribution Channel 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel 9.4. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, By Distribution Channel 9.5. Global Motion Sickness Treatment Market Analysis, By Distribution Channel 9.6. Global Motion Sickness Treatment Market Attractiveness Analysis, By Distribution Channel 10. Motion Sickness Treatment Market Analysis, by Region 10.1. Global Motion Sickness Treatment Market Value Share Analysis, by Region 10.2. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, by Region 10.3. Global Motion Sickness Treatment Market Attractiveness Analysis, by Region 11. North America Motion Sickness Treatment Market Analysis 11.1. Key Findings 11.2. North America Motion Sickness Treatment Market Overview 11.3. North America Motion Sickness Treatment Market Value Share Analysis, By Treatment Type 11.4. North America Motion Sickness Treatment Market Forecast, By Treatment Type 11.4.1. Anticholinergic 11.4.2. Antihistamines Sympathomimetic 11.4.3. Traditional Medicines 11.4.4. Others 11.5. North America Motion Sickness Treatment Market Value Share Analysis, By Route of Administration 11.6. North America Motion Sickness Treatment Market Forecast, By Route of Administration 11.6.1. Oral 11.6.2. Transdermal 11.6.3. Parenteral 11.6.4. Other 11.7. North America Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel 11.8. North America Motion Sickness Treatment Market Forecast, By Distribution Channel 11.8.1. Retail Pharmacies 11.8.2. Online Pharmacies 11.8.3. Drug Stores 11.8.4. Others 11.9. North America Motion Sickness Treatment Market Value Share Analysis, by Country 11.10. North America Motion Sickness Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Motion Sickness Treatment Market Analysis, by Country 11.12. U.S. Motion Sickness Treatment Market Forecast, By Treatment Type 11.12.1. Anticholinergic 11.12.2. Antihistamines Sympathomimetic 11.12.3. Traditional Medicines 11.12.4. Others 11.13. U.S. Motion Sickness Treatment Market Forecast, By Route of Administration 11.13.1. Oral 11.13.2. Transdermal 11.13.3. Parenteral 11.13.4. Other 11.14. U.S. Motion Sickness Treatment Market Forecast, By Distribution Channel 11.14.1. Retail Pharmacies 11.14.2. Online Pharmacies 11.14.3. Drug Stores 11.14.4. Others 11.15. Canada Motion Sickness Treatment Market Forecast, By Treatment Type 11.15.1. Anticholinergic 11.15.2. Antihistamines Sympathomimetic 11.15.3. Traditional Medicines 11.15.4. Others 11.16. Canada Motion Sickness Treatment Market Forecast, By Route of Administration 11.16.1. Oral 11.16.2. Transdermal 11.16.3. Parenteral 11.16.4. Other 11.17. Canada Motion Sickness Treatment Market Forecast, By Distribution Channel 11.17.1. Retail Pharmacies 11.17.2. Online Pharmacies 11.17.3. Drug Stores 11.17.4. Others 11.18. North America Motion Sickness Treatment Market Attractiveness Analysis 11.18.1. By Treatment Type 11.18.2. By Route of Administration 11.18.3. By Distribution Channel 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Motion Sickness Treatment Market Analysis 12.1. Key Findings 12.2. Europe Motion Sickness Treatment Market Overview 12.3. Europe Motion Sickness Treatment Market Value Share Analysis, By Treatment Type 12.4. Europe Motion Sickness Treatment Market Forecast, By Treatment Type 12.4.1. Anticholinergic 12.4.2. Antihistamines Sympathomimetic 12.4.3. Traditional Medicines 12.4.4. Others 12.5. Europe Motion Sickness Treatment Market Value Share Analysis, By Route of Administration 12.6. Europe Motion Sickness Treatment Market Forecast, By Route of Administration 12.6.1. Oral 12.6.2. Transdermal 12.6.3. Parenteral 12.6.4. Other 12.7. Europe Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel 12.8. Europe Motion Sickness Treatment Market Forecast, By Distribution Channel 12.8.1. Retail Pharmacies 12.8.2. Online Pharmacies 12.8.3. Drug Stores 12.8.4. Others 12.9. Europe Motion Sickness Treatment Market Value Share Analysis, by Country 12.10. Europe Motion Sickness Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Motion Sickness Treatment Market Analysis, by Country 12.12. Germany Motion Sickness Treatment Market Forecast, By Treatment Type 12.12.1. Anticholinergic 12.12.2. Antihistamines Sympathomimetic 12.12.3. Traditional Medicines 12.12.4. Others 12.13. Germany Motion Sickness Treatment Market Forecast, By Route of Administration 12.13.1. Oral 12.13.2. Transdermal 12.13.3. Parenteral 12.13.4. Other 12.14. Germany Motion Sickness Treatment Market Forecast, By Distribution Channel 12.14.1. Retail Pharmacies 12.14.2. Online Pharmacies 12.14.3. Drug Stores 12.14.4. Others 12.15. U.K. Motion Sickness Treatment Market Forecast, By Treatment Type 12.15.1. Anticholinergic 12.15.2. Antihistamines Sympathomimetic 12.15.3. Traditional Medicines 12.15.4. Others 12.16. U.K. Motion Sickness Treatment Market Forecast, By Route of Administration 12.16.1. Oral 12.16.2. Transdermal 12.16.3. Parenteral 12.16.4. Other 12.17. U.K. Motion Sickness Treatment Market Forecast, By Distribution Channel 12.17.1. Retail Pharmacies 12.17.2. Online Pharmacies 12.17.3. Drug Stores 12.17.4. Others 12.18. France Motion Sickness Treatment Market Forecast, By Treatment Type 12.18.1. Anticholinergic 12.18.2. Antihistamines Sympathomimetic 12.18.3. Traditional Medicines 12.18.4. Others 12.19. France Motion Sickness Treatment Market Forecast, By Route of Administration 12.19.1. Oral 12.19.2. Transdermal 12.19.3. Parenteral 12.19.4. Other 12.20. France Motion Sickness Treatment Market Forecast, By Distribution Channel 12.20.1. Retail Pharmacies 12.20.2. Online Pharmacies 12.20.3. Drug Stores 12.20.4. Others 12.21. Italy Motion Sickness Treatment Market Forecast, By Treatment Type 12.21.1. Anticholinergic 12.21.2. Antihistamines Sympathomimetic 12.21.3. Traditional Medicines 12.21.4. Others 12.22. Italy Motion Sickness Treatment Market Forecast, By Route of Administration 12.22.1. Oral 12.22.2. Transdermal 12.22.3. Parenteral 12.22.4. Other 12.23. Italy Motion Sickness Treatment Market Forecast, By Distribution Channel 12.23.1. Retail Pharmacies 12.23.2. Online Pharmacies 12.23.3. Drug Stores 12.23.4. Others 12.24. Spain Motion Sickness Treatment Market Forecast, By Treatment Type 12.24.1. Anticholinergic 12.24.2. Antihistamines Sympathomimetic 12.24.3. Traditional Medicines 12.24.4. Others 12.25. Spain Motion Sickness Treatment Market Forecast, By Route of Administration 12.25.1. Oral 12.25.2. Transdermal 12.25.3. Parenteral 12.25.4. Other 12.26. Spain Motion Sickness Treatment Market Forecast, By Distribution Channel 12.26.1. Retail Pharmacies 12.26.2. Online Pharmacies 12.26.3. Drug Stores 12.26.4. Others 12.27. Rest of Europe Motion Sickness Treatment Market Forecast, By Treatment Type 12.27.1. Anticholinergic 12.27.2. Antihistamines Sympathomimetic 12.27.3. Traditional Medicines 12.27.4. Others 12.28. Rest of Europe Motion Sickness Treatment Market Forecast, By Route of Administration 12.28.1. Oral 12.28.2. Transdermal 12.28.3. Parenteral 12.28.4. Other 12.29. Rest of Europe Motion Sickness Treatment Market Forecast, By Distribution Channel 12.29.1. Retail Pharmacies 12.29.2. Online Pharmacies 12.29.3. Drug Stores 12.29.4. Others 12.30. Europe Motion Sickness Treatment Market Attractiveness Analysis 12.30.1. By Treatment Type 12.30.2. By Route of Administration 12.30.3. By Distribution Channel 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Motion Sickness Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Motion Sickness Treatment Market Overview 13.3. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, By Treatment Type 13.4. Asia Pacific Motion Sickness Treatment Market Forecast, By Treatment Type 13.4.1. Anticholinergic 13.4.2. Antihistamines Sympathomimetic 13.4.3. Traditional Medicines 13.4.4. Others 13.5. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, By Route of Administration 13.6. Asia Pacific Motion Sickness Treatment Market Forecast, By Route of Administration 13.6.1. Oral 13.6.2. Transdermal 13.6.3. Parenteral 13.6.4. Other 13.7. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel 13.8. Asia Pacific Motion Sickness Treatment Market Forecast, By Distribution Channel 13.8.1. Retail Pharmacies 13.8.2. Online Pharmacies 13.8.3. Drug Stores 13.8.4. Others 13.9. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Motion Sickness Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Motion Sickness Treatment Market Analysis, by Country 13.12. China Motion Sickness Treatment Market Forecast, By Treatment Type 13.12.1. Anticholinergic 13.12.2. Antihistamines Sympathomimetic 13.12.3. Traditional Medicines 13.12.4. Others 13.13. China Motion Sickness Treatment Market Forecast, By Route of Administration 13.13.1. Oral 13.13.2. Transdermal 13.13.3. Parenteral 13.13.4. Other 13.14. China Motion Sickness Treatment Market Forecast, By Distribution Channel 13.14.1. Retail Pharmacies 13.14.2. Online Pharmacies 13.14.3. Drug Stores 13.14.4. Others 13.15. India Motion Sickness Treatment Market Forecast, By Treatment Type 13.15.1. Anticholinergic 13.15.2. Antihistamines Sympathomimetic 13.15.3. Traditional Medicines 13.15.4. Others 13.16. India Motion Sickness Treatment Market Forecast, By Route of Administration 13.16.1. Oral 13.16.2. Transdermal 13.16.3. Parenteral 13.16.4. Other 13.17. India Motion Sickness Treatment Market Forecast, By Distribution Channel 13.17.1. Retail Pharmacies 13.17.2. Online Pharmacies 13.17.3. Drug Stores 13.17.4. Others 13.18. Japan Motion Sickness Treatment Market Forecast, By Treatment Type 13.18.1. Anticholinergic 13.18.2. Antihistamines Sympathomimetic 13.18.3. Traditional Medicines 13.18.4. Others 13.19. Japan Motion Sickness Treatment Market Forecast, By Route of Administration 13.19.1. Oral 13.19.2. Transdermal 13.19.3. Parenteral 13.19.4. Other 13.20. Japan Motion Sickness Treatment Market Forecast, By Distribution Channel 13.20.1. Retail Pharmacies 13.20.2. Online Pharmacies 13.20.3. Drug Stores 13.20.4. Others 13.21. ASEAN Motion Sickness Treatment Market Forecast, By Treatment Type 13.21.1. Anticholinergic 13.21.2. Antihistamines Sympathomimetic 13.21.3. Traditional Medicines 13.21.4. Others 13.22. ASEAN Motion Sickness Treatment Market Forecast, By Route of Administration 13.22.1. Oral 13.22.2. Transdermal 13.22.3. Parenteral 13.22.4. Other 13.23. ASEAN Motion Sickness Treatment Market Forecast, By Distribution Channel 13.23.1. Retail Pharmacies 13.23.2. Online Pharmacies 13.23.3. Drug Stores 13.23.4. Others 13.24. Rest of Asia Pacific Motion Sickness Treatment Market Forecast, By Treatment Type 13.24.1. Anticholinergic 13.24.2. Antihistamines Sympathomimetic 13.24.3. Traditional Medicines 13.24.4. Others 13.25. Rest of Asia Pacific Motion Sickness Treatment Market Forecast, By Route of Administration 13.25.1. Oral 13.25.2. Transdermal 13.25.3. Parenteral 13.25.4. Other 13.26. Rest of Asia Pacific Motion Sickness Treatment Market Forecast, By Distribution Channel 13.26.1. Retail Pharmacies 13.26.2. Online Pharmacies 13.26.3. Drug Stores 13.26.4. Others 13.27. Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis 13.27.1. By Treatment Type 13.27.2. By Route of Administration 13.27.3. By Distribution Channel 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Motion Sickness Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Motion Sickness Treatment Market Overview 14.3. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, By Treatment Type 14.4. Middle East & Africa Motion Sickness Treatment Market Forecast, By Treatment Type 14.4.1. Anticholinergic 14.4.2. Antihistamines Sympathomimetic 14.4.3. Traditional Medicines 14.4.4. Others 14.5. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, By Route of Administration 14.6. Middle East & Africa Motion Sickness Treatment Market Forecast, By Route of Administration 14.6.1. Oral 14.6.2. Transdermal 14.6.3. Parenteral 14.7. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel 14.8. Middle East & Africa Motion Sickness Treatment Market Forecast, By Distribution Channel 14.8.1. Retail Pharmacies 14.8.2. Online Pharmacies 14.8.3. Drug Stores 14.8.4. Others 14.9. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Motion Sickness Treatment Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Motion Sickness Treatment Market Analysis, by Country 14.12. GCC Motion Sickness Treatment Market Forecast, By Treatment Type 14.12.1. Anticholinergic 14.12.2. Antihistamines Sympathomimetic 14.12.3. Traditional Medicines 14.12.4. Others 14.13. GCC Motion Sickness Treatment Market Forecast, By Route of Administration 14.13.1. Oral 14.13.2. Transdermal 14.13.3. Parenteral 14.13.4. Other 14.14. GCC Motion Sickness Treatment Market Forecast, By Distribution Channel 14.14.1. Retail Pharmacies 14.14.2. Online Pharmacies 14.14.3. Drug Stores 14.14.4. Others 14.15. South Africa Motion Sickness Treatment Market Forecast, By Route of Administration 14.15.1. Oral 14.15.2. Transdermal 14.15.3. Parenteral 14.15.4. Other 14.16. South Africa Motion Sickness Treatment Market Forecast, By Distribution Channel 14.16.1. Retail Pharmacies 14.16.2. Online Pharmacies 14.16.3. Drug Stores 14.16.4. Others 14.17. Rest of Middle East & Africa Motion Sickness Treatment Market Forecast, By Treatment Type 14.17.1. Anticholinergic 14.17.2. Antihistamines Sympathomimetic 14.17.3. Traditional Medicines 14.17.4. Others 14.18. Rest of Middle East & Africa Motion Sickness Treatment Market Forecast, By Route of Administration 14.18.1. Oral 14.18.2. Transdermal 14.18.3. Parenteral 14.18.4. Other 14.19. Rest of Middle East & Africa Motion Sickness Treatment Market Forecast, By Distribution Channel 14.19.1. Retail Pharmacies 14.19.2. Online Pharmacies 14.19.3. Drug Stores 14.19.4. Others 14.20. Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis 14.20.1. By Treatment Type 14.20.2. By Route of Administration 14.20.3. By Distribution Channel 14.21. PEST Analysis 14.22. Key Trends 14.23. Key Developments 15. South America Motion Sickness Treatment Market Analysis 15.1. Key Findings 15.2. South America Motion Sickness Treatment Market Overview 15.3. South America Motion Sickness Treatment Market Value Share Analysis, By Treatment Type 15.4. South America Motion Sickness Treatment Market Forecast, By Treatment Type 15.4.1. Anticholinergic 15.4.2. Antihistamines Sympathomimetic 15.4.3. Traditional Medicines 15.4.4. Others 15.5. South America Motion Sickness Treatment Market Value Share Analysis, By Route of Administration 15.6. South America Motion Sickness Treatment Market Forecast, By Route of Administration 15.6.1. Oral 15.6.2. Transdermal 15.6.3. Parenteral 15.6.4. Other 15.7. South America Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel 15.8. South America Motion Sickness Treatment Market Forecast, By Distribution Channel 15.8.1. Retail Pharmacies 15.8.2. Online Pharmacies 15.8.3. Drug Stores 15.8.4. Others 15.9. South America Motion Sickness Treatment Market Value Share Analysis, by Country 15.10. South America Motion Sickness Treatment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Motion Sickness Treatment Market Analysis, by Country 15.12. Brazil Motion Sickness Treatment Market Forecast, By Treatment Type 15.12.1. Anticholinergic 15.12.2. Antihistamines Sympathomimetic 15.12.3. Traditional Medicines 15.12.4. Others 15.13. Brazil Motion Sickness Treatment Market Forecast, By Route of Administration 15.13.1. Oral 15.13.2. Transdermal 15.13.3. Parenteral 15.13.4. Other 15.14. Brazil Motion Sickness Treatment Market Forecast, By Distribution Channel 15.14.1. Retail Pharmacies 15.14.2. Online Pharmacies 15.14.3. Drug Stores 15.14.4. Others 15.15. Mexico Motion Sickness Treatment Market Forecast, By Treatment Type 15.15.1. Anticholinergic 15.15.2. Antihistamines Sympathomimetic 15.15.3. Traditional Medicines 15.15.4. Others 15.16. Mexico Motion Sickness Treatment Market Forecast, By Route of Administration 15.16.1. Oral 15.16.2. Transdermal 15.16.3. Parenteral 15.16.4. Other 15.17. Mexico Motion Sickness Treatment Market Forecast, By Distribution Channel 15.17.1. Retail Pharmacies 15.17.2. Online Pharmacies 15.17.3. Drug Stores 15.17.4. Others 15.18. Rest of South America Motion Sickness Treatment Market Forecast, By Treatment Type 15.18.1. Anticholinergic 15.18.2. Antihistamines Sympathomimetic 15.18.3. Traditional Medicines 15.18.4. Others 15.19. Rest of South America Motion Sickness Treatment Market Forecast, By Route of Administration 15.19.1. Oral 15.19.2. Transdermal 15.19.3. Parenteral 15.19.4. Other 15.20. Rest of South America Motion Sickness Treatment Market Forecast, By Distribution Channel 15.20.1. Retail Pharmacies 15.20.2. Online Pharmacies 15.20.3. Drug Stores 15.20.4. Others 15.21. South America Motion Sickness Treatment Market Attractiveness Analysis 15.21.1. By Treatment Type 15.21.2. By Route of Administration 15.21.3. By Distribution Channel 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Route of Administrations and R&D investment 16.2.2. New Treatment Center Launches and Treatment Center Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Route of Administrations 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. GlaxoSmithKline plc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Treatment Center Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Perrigo Company plc. 16.3.3. Prestige Brands Inc. 16.3.4. WellSpring Pharmaceutical Corporation 16.3.5. Caleb Pharmaceuticals Inc. 16.3.6. Myungmoon Pharm Co. Ltd. 16.3.7. Baxter International Inc. 16.3.8. Reliefband Technologies LLC. 16.3.9. CVS Health. 17. Primary Key Insights